SymBio Pharmaceuticals Limited
4582.T
Price:
$161
Market Cap:
$7.84B
SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical drugs in the areas of oncology and hematology in Japan. It is involved in the development of Treakisym SyB L-0501, an anti-cancer agent, which is marketed for the treatment of non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia under the TREAKISYM name; and is in the Phase III clinical trial to treat relapsed/refractory diffuse large B-cell lymphoma. The company also engages in the development of SyB L-1701, a ready-to-dilute formulation; and SyB L-1702, a rapid infusion liquid formulation. In addition, it is involved in the development of SyB L-1101, ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-10-20
Stock Exchange
JPX
Ticker
4582.T
PE Ratio
[-1.70]
ROE
[-67.25%]
Current Ratio
[6.43]
Dividend Yield
[0%]
Enterprise Value
[3.88B]
Dividend History
The PE Ratio as of May 2025 (TTM) for SymBio Pharmaceuticals Limited (4582.T) is -1.70
According to SymBio Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.70. This represents a change of -27.80% compared to the average of -2.35 of the last 4 quarters.
SymBio Pharmaceuticals Limited (4582.T) Historical PE Ratio (quarterly & annually)
How has 4582.T PE Ratio performed in the past?
The mean historical PE Ratio of SymBio Pharmaceuticals Limited over the last ten years is 1.49. The current -1.70 PE Ratio has changed -11500.50% with respect to the historical average. Over the past ten years (40 quarters), 4582.T's PE Ratio was at its highest in in the June 2021 quarter at 5.58K. The PE Ratio was at its lowest in in the March 2021 quarter at -51.49.
Average
1.49
Median
-2.95
Minimum
-5.02
Maximum
21.59
SymBio Pharmaceuticals Limited (4582.T) PE Ratio by Quarter and Year
Discovering the peaks and valleys of SymBio Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 67.26%
Maximum Annual PE Ratio = 21.59
Minimum Annual Increase = -807.03%
Minimum Annual PE Ratio = -5.02
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.34 | -53.38% |
| 2023 | -5.02 | -123.58% |
| 2022 | 21.29 | -1.37% |
| 2021 | 21.59 | -807.03% |
| 2020 | -3.05 | -4.92% |
| 2019 | -3.21 | -30.06% |
| 2018 | -4.59 | 67.26% |
| 2017 | -2.74 | -33.83% |
| 2016 | -4.15 | 45.31% |
| 2015 | -2.86 | -71.00% |
SymBio Pharmaceuticals Limited (4582.T) Average PE Ratio
How has 4582.T PE Ratio performed in the past?
The current PE Ratio of SymBio Pharmaceuticals Limited (4582.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.64
5-year avg
6.49
10-year avg
1.49
SymBio Pharmaceuticals Limited (4582.T) PE Ratio vs. Peers
How is 4582.T’s PE Ratio compared to its peers?
SymBio Pharmaceuticals Limited’s PE Ratio is less than AnGes, Inc. (-0.67), greater than Sumitomo Pharma Co., Ltd. (-1.77), greater than Solasia Pharma K.K. (-3.37), greater than Ribomic Inc. (-3.68), less than Nippon Shinyaku Co., Ltd. (7.65),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.67 | $22.64B | |
| -1.77 | $311.08B | |
| -3.37 | $6.58B | |
| -3.68 | $3.83B | |
| 7.65 | $232.66B |
Build a custom stock screener for SymBio Pharmaceuticals Limited (4582.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SymBio Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
SymBio Pharmaceuticals Limited (4582.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like SymBio Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is SymBio Pharmaceuticals Limited's PE Ratio?
How is the PE Ratio calculated for SymBio Pharmaceuticals Limited (4582.T)?
What is the highest PE Ratio for SymBio Pharmaceuticals Limited (4582.T)?
What is the 3-year average PE Ratio for SymBio Pharmaceuticals Limited (4582.T)?
What is the 5-year average PE Ratio for SymBio Pharmaceuticals Limited (4582.T)?
How does the current PE Ratio for SymBio Pharmaceuticals Limited (4582.T) compare to its historical average?